NEWSWIRETODAY Press Release & Newswire Distribution | HOME
MOST TRUSTED NEWSWIRE PRESS RELEASE DISTRIBUTION
PRTODAY / NewswireToday press release distribution service network
Agency / Source: Biotage

Check Ads Availability|e-mail Article

Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!

Peptide Synthesis Webinar Series Second Installment - Synthesis of Difficult Peptide Sequences - Biotage announces the second installment in its series of webinars focusing on peptide synthesis. The free events are in part a result of the research collaboration with the Faculty of Life Sciences, University of Copenhagen (STO: BIOT)
Peptide Synthesis Webinar Series Second Installment - Synthesis of Difficult Peptide Sequences

 

NewswireTODAY - /newswire/ - Uppsala, Sweden, 2010/10/25 - Biotage announces the second installment in its series of webinars focusing on peptide synthesis. The free events are in part a result of the research collaboration with the Faculty of Life Sciences, University of Copenhagen (STO: BIOT).

   
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma / BioTech / Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Biotage, a leading supplier of tools and technology for medicinal and analytical chemistry, announced the second installment in its series of webinars focusing on peptide synthesis. The free events are in part a result of the research collaboration with Professor Knud J. Jensen at the Faculty of Life Sciences, University of Copenhagen, in developing new applications on the Biotage Syro Wave™ Parallel Peptide Synthesizer in the field of synthetic peptide and protein chemistry. The collaboration builds on Professor Jensen’s previous research in developing novel chemistries for applications of solid-phase peptide synthesis.

There is no charge for the webinar series which is available for viewing at biotage.com/peptides.

Introduced today is the second installment in the webinar series: Robotic Peptide Synthesizer with Microwave Heating, Synthesis of Difficult Peptide Sequences. Presented at the 31st European Peptide Symposium, Copenhagen, Denmark 2010, by A. Pernille Tofteng, Faculty of Life Sciences, University of Copenhagen

The popular first webinar in the series: Microwave & Parallel Peptide Synthesizer: The Best of Both Worlds was also presented at the 31st European Peptide Symposium in Copenhagen, by Amit Mehrotra - Product Manager, Synthesis and Marketing Manager, Peptide Chemistry.

“We are very excited with the positive response we’ve received from professionals around the world regarding this webinar series.” says Amit Mehrotra “These free webinars are available at biotage.com/peptides, our dedicated resource for professionals. Coupled with our ongoing introduction of new products, our efforts illustrate that Biotage is dedicated to peptide professionals and are without question a leader in this important area.”

The webinar series was announced following the recent introduction of Biotage Resolux™ HPLC columns for peptide purification. Resolux premiered at the ACS Fall 2010 National Meeting & Exposition in Boston, Massachusetts USA and at the 31st European Peptide Symposium in Copenhagen, Denmark.

For further press information at Biotage please contact: Rob Thompson, Director of Marketing Communications, 10430 Harris Oaks Blvd., Suite C, Charlotte, NC USA 28269 T: +1 704 654 4847; F: +1 704 654 4917; E: rob.thompson[.]biotage.com

About Biotage
Biotage (biotage.com) offers solutions, knowledge and experience in the areas of analytical and organic chemistry. The customers include the world’s top pharma and biotech companies, as well as leading academic institutes. The company is headquartered in Uppsala, Sweden, and has offices in the United States, United Kingdom and Japan. Biotage has 245 employees and had sales of SEK 394,1m in 2009. Biotage is listed on the NASDAQ OMX Nordic Stock Exchange.

 
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma / BioTech / Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Agency / Source: Biotage

 
 

Availability: All Regions (Including Int'l)

 

Traffic Booster: [/] Quick NewswireToday Visibility Checker

 

Distribution / Indexing: [+]

 
 
# # #
 

 
  Your Banner Ad showing on ALL
Pharma / BioTech / Nutrition articles,
CATCH Visitors via Your Competitors Announcements!


Peptide Synthesis Webinar Series Second Installment - Synthesis of Difficult Peptide Sequences

Company website links NOT available to basic submissions
It is OK to republish and/or LINK any newswire for any legitimate media purpose as long as you name NewswireToday and LINK as the source.
 
  For more information, please visit:
Is this your article? Activate ALL web links by Upgrading to Press Release PREMIUM Plan Now!
|
Contact: Rob Thompson - Biotage.com 
704-654-4900 product_info[.]biotage.com
 
PRZOOM / PRTODAY - Newswire Today disclaims any content contained in this article. If you need/wish to contact the company who published the current release, you will need to contact them - NOT us. Issuers of articles are solely responsible for the accuracy of their content. Our complete disclaimer appears here.
IMPORTANT INFORMATION: Issuance, publication or distribution of this press release in certain jurisdictions could be subject to restrictions. The recipient of this press release is responsible for using this press release and the information herein in accordance with the applicable rules and regulations in the particular jurisdiction. This press release does not constitute an offer or an offering to acquire or subscribe for any Biotage securities in any jurisdiction including any other companies listed or named in this release.

Pharma / BioTech / Nutrition via RSSAdd NewswireToday - PRZOOM Headline News to FeedBurner
Find who RetweetFollow @NewswireTODAY

Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!


Read Latest Articles From Biotage / Company Profile


Read Pharma / BioTech / Nutrition Most Recent Related Newswires:

IQIRVO® Demonstrates Statistically Significant Improvement in ALP Normalization in Patients with PBC in Phase IIIb ELSPIRE Study
Dysport® is the First Botulinum Toxin to Achieve Positive Topline Phase III Results in Both Episodic and Chronic Migraine
STEMCELL Technologies and CCRM Partner to Expand Access to Matched GMP and RUO iPSC Lines for Cell Therapy Development
Ipsen to Acquire Memo Therapeutics AG - Adding First-in-class BK Polyomavirus Antibody, Expanding Rare Disease Portfolio
Ipsen to Acquire Kartos Therapeutics, Expanding Hemato-oncology Late-stage Pipeline
Ono Pharma Submits a Supplemental Application in Japan to Expand the Use of VELEXBRU® Tablets for the Treatment of Central Nervous System Involvement
Ono Pharma Announces Poster Presentation of New Clinical Data from Phase 2 Study of ONO-2808 in Multiple System Atrophy At the 7th World Parkinson Con
Ipsen Announces Late-breaking Data from First Head-to-head Study Comparing Dysport® and Botox® in Adults with Upper Limb Spasticity
Ipsen Unveils Corabotase, A First-in-class Recombinant Neuroinhibitor, RNI™ At the SCALE Symposium
SCHOTT Pharma Expands Portfolio for Sensitive Biologics with CartriQ® BioPure
Ojemda® Approved in The European Union as the First Targeted Therapy in Relapsed or Refractory Pediatric Low-grade Glioma
Ono Pharma Submits an Application for Approval of Ripretinib (DCC-2618) in Patients with Advanced Gastrointestinal Stromal Tumor in Japan
Locus FS Receives the 2026 North American Precision Fermentation Technology Innovation Leadership Recognition
Ipsen Showcases Transformative Potential of Early Immuno-oncology Pipeline At AACR
Ono Pharma Announces New Drug Discovery Collaboration with Congruence Therapeutics in the Priority Areas of Neurology and Immunology

Boost Your Social Network
& Crowdfunding Campaigns


LIFETIME SOCIAL MEDIA WALL
NewswireToday Celebrates 10 Years in Business


PREMIUM Members


Visit BizJobs.com

Visit  La Bella Bakery Artisan Bakery Arizona





 
  ©2005-2026 NewswireToday — Limelon Advertising, Co.
Home | About | Advertise/Pricing | Contact | Investors | Privacy/TOS | Sitemap | FRANCAIS
newswire, PR press releases distribution service magazines engine news alert newsroom press room breaking news public relations articles company news alerts newswiredistribution ezine bizentrepreneur biznewstoday digital business report market search pr firms agencies reports distri-bution today investor relation successful internet entrepreneurs newswire distribution prtoday.com newswiredistribution asianewstoday bizwiretoday USA pr UK today - NOT affiliated with PRNewswire as we declined their partnership offer in 2013
 
PRTODAY & NewswireTODAY are NOT affiliated with USA TODAY (usatoday.com)